Nov 15, 2024, 16:30
Virginia Kakla Mani: New Screening Practices and Therapeutic Insights for HR+ Breast Cancer
Virginia Kakla Mani, Professor of Medicine at UT Health San Antonio, share a post on X:
“Estrogen receptor mutations impact treatment in HR+ breast cancer.
I’ll be discussing new screening practices and therapeutic insights with Clinical Care Options at an upcoming live satellite symposium.
I hope you can join me.”
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 5, 2024, 07:39
Dec 5, 2024, 07:37
Dec 5, 2024, 07:28
Dec 5, 2024, 00:57
Dec 5, 2024, 00:45
Dec 5, 2024, 00:30
Dec 5, 2024, 00:09